Munich, Germany

Robert Eckl


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • München, DE (2004 - 2007)
  • Mehring, DE (2016)

Company Filing History:


Years Active: 2004-2016

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Inventor Robert Eckl

Introduction

Robert Eckl, an innovative inventor based in Munich, Germany, has made significant contributions to the field of pharmaceutical sciences. With a total of two patents to his name, Eckl's work focuses primarily on compounds that exhibit inhibitory effects on Factor Xa activity. His inventions hold potential in the treatment and prevention of various diseases linked to this critical biological pathway.

Latest Patents

Eckl's latest patents detail compounds that inhibit Factor Xa activity. This invention encompasses a range of compounds characterized by specific formulas or their pharmaceutically acceptable salts, solvates, hydrates, or formulations. The primary application of these compounds is in the inhibition of Factor Xa, facilitating advancements in therapeutic approaches for diseases mediated by Factor Xa activity.

Career Highlights

Robert Eckl has worked with renowned companies such as Morphochem AG and Morphochem GmbH. His tenure at these organizations has been marked by a dedication to developing innovative therapeutic solutions, showcasing his commitment to advancing medical science through invention.

Collaborations

Throughout his career, Eckl has collaborated with esteemed colleagues, including Thilo Fuchs and Michael W. Cappi. These partnerships have undoubtedly contributed to the development and realization of his innovative ideas, fostering a collaborative spirit in the realm of pharmaceutical innovation.

Conclusion

In conclusion, Robert Eckl's contributions to the domain of pharmaceutical inventions are noteworthy. His patents focusing on Factor Xa inhibitors represent a notable advancement in medical therapeutics. Through his innovative work and collaborations, Eckl continues to impact the scientific community positively, paving the way for future breakthroughs in treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…